Skip to content

The effects of Caffeine on Attentional Networks

The effects of Caffeine on Attentional Networks in Healthy Volunteers

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000115235
Enrollment
26
Registered
2018-01-29
Start date
2018-05-16
Completion date
2019-05-29
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will will address the gaps in the literature by exploring the underlying neural correlates of an acute dose of caffeine using both an attentional network task and a flanker Go/NoGo task. Specifically, caffeine is expected to improve the alerting and executive control networks of attention, but not the orienting network. For the attentional network task, it is hypothesised there will be a reduction in reaction time and an increase brain activity (N1 amplitude) following alerting (central) but not orienting (spatial) cues after caffeine ingestion in comparison to placebo. For the flanker go/nogo task, it is hypothesised that Reaction Time and brain activity (N2 amplitude) will be greater for incongruent relative to congruent trials, and that this flanker interference effect would be reduced from pre- to post-ingestion for caffeine relative to placebo.

Interventions

Acute (1 day) oral ingestion of 200mg Caffeine (2 x capsules) with a one-week washout period. Adherence monitored via direct observation by study staff.

Sponsors

University of Tasmania
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

Participation will be restricted to low caffeine users (less than 100mg per day) as assessed by the Caffeine and energy drink questionnaire.

Exclusion criteria

Exclusion criteria will include serious physical or neurological conditions, current or notable past history of mental health conditions), current use of psychoactive medications, recent or notable past history of illicit drug use, daily tobacco use, risk of alcohol dependence as measured by the Alcohol Use and Disorders Identification Test (AUDIT; defined as >= 16), high levels of psychological distress measured by Kessler Psychological Scale (K10; defined as >= 30), or contraindications to caffeine such as hypertension or anxiety. All participants will have English as their first language and normal or corrected-to-normal vision and hearing. Females will be excluded if they are currently pregnant or if there is any chance that they may be pregnant.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026